Showing results (471-480 of 576) with videos related to
Sort By:
Pageof 58
New Biotechnology|January 18, 2019
Hydrocarbonoclastic Ascomycetes to enhance co-composting of total petroleum hydrocarbon (TPH) contaminated dredged sediments and lignocellulosic matricesSimone Becarelli, Ilaria Chicca, Giovanna Siracusa, et al.Bipolar Disorders|November 12, 2025
Association Between Adherence Barriers, Self-Reported Adherence, and Psychiatric Symptoms Among Adults With Bipolar DisorderMartha Sajatovic, Jennifer B Levin, Clara Adeniyi, et al.Cancer Research|July 15, 1989
Phase I trial of recombinant human gamma-interferon and recombinant human tumor necrosis factor in patients with advanced gastrointestinal cancerJ L Abbruzzese, B Levin, J A Ajani, et al.Investigational New Drugs|November 1, 1991
Phase II study of intravenous 6-thioguanine in patients with advanced carcinoma of the pancreasJ A Ajani, R Pazdur, R J Winn, et al.International Journal of Healthcare|February 6, 2023
Effective engagement of a stakeholder advisory board in severe mental illness (SMI) research: A case study of a clinical trial to improve adherence among people with SMI and hypertensionDafna Paltin, Jessica L Montoya, Celeste Weise, et al.Applied and Environmental Microbiology|December 24, 2013
Thermoanaerobacter thermohydrosulfuricus WC1 shows protein complement stability during fermentation of key lignocellulose-derived substratesTobin J Verbeke, Vic Spicer, Oleg V Krokhin, et al.Bipolar Disorders|November 4, 2015
Symptom severity, self-reported adherence, and electronic pill monitoring in poorly adherent patients with bipolar disorderMartha Sajatovic, Jennifer B Levin, Johnny Sams, et al.Public Health Reviews|January 10, 2002
Planning cancer prevention strategies based on epidemiologic characteristics: an Egyptian exampleA S Soliman, B Levin, S El-Badawy, et al.Neurology|January 12, 2005
The ALSFRSr predicts survival time in an ALS clinic populationP Kaufmann, G Levy, J L P Thompson, et al.Journal of Clinical Psychopharmacology|September 21, 2017
A 6-Month Prospective Trial of a Personalized Behavioral Intervention + Long-Acting Injectable Antipsychotic in Individuals With Schizophrenia at Risk of Treatment Nonadherence and HomelessnessMartha Sajatovic, Luis F Ramirez, Edna Fuentes-Casiano, et al.Pageof 58